{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T03:19:47Z","timestamp":1781666387598,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>We used state-of-the-art high-resolution retinal imaging to explore the treatment (loading dose of aflibercept) of diabetic macular edema (DME) among treatment-naive patients. Swept-source (SS) OCT and OCT-Angiography (SS-OCTA) were performed, and a dichotomous analysis was conducted to compare responders and treatment-resistant patients (responsive and resistant). Furthermore, treatment responses were evaluated based on the subdivision of choroidal thickness.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and methods<\/jats:title>\n            <jats:p>This prospective, noncomparative, interventional case series study examined the following biomarkers: best-corrected visual acuity (BCVA), central macular thickness (CMT), central choroidal thickness (CCT), avascular area of the superficial plexus (AASP), avascular area of the deep plexus (AADP), and vessel density (VD). Data from the baseline and 4-month examinations were compared.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Twenty-eight eyes from 25 patients were included. Significant improvements were observed in BCVA (0.7250\u2009\u00b1\u20090.23 to 0.3957\u2009\u00b1\u20090.21; p\u2009&lt;\u20090.000), CMT \u00b5m (339.04\u2009\u00b1\u200966.19 to 265.21\u2009\u00b1\u200955.75; p\u2009&lt;\u20090.000), CCT \u00b5m (221.71\u2009\u00b1\u200969.69 to 209.07\u2009\u00b1\u200970.92; p\u2009&lt;\u20090.000), VD (17.90\u2009\u00b1\u20097.82 to 15.35\u2009\u00b1\u20095.80; p\u2009&lt;\u20090.038), AASP \u00b5m<jats:sup>2<\/jats:sup> (235,374\u2009\u00b1\u200991,299 to 157,326\u2009\u00b1\u200977,815; p\u2009&lt;\u20090.000) and AADP \u00b5m<jats:sup>2<\/jats:sup> (996,335\u2009\u00b1\u20091,000,047 to 362,161\u2009\u00b1\u2009277,225; p\u2009&lt;\u20090.000). Dichotomous analysis revealed that 15 patients were responsive (53.57%), and 13 resistant (46.43%). There were no significant differences between any of the pretreatment biomarkers. In the subdivision of choroidal thickness, which ranged from 211 to 270\u00a0\u00b5m (group 3), we found greater reductions in the CCT, AADP and CD. The choroidal thickness ranged from 181 to 210\u00a0\u00b5m (group 2): BCVA and AASP exhibited the greatest reductions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>BCVA, CMT, CCT, AASP, AADP and VD were improved after treatment. The pretreatment biomarkers did not predict treatment response between the responsive and resistant. Regarding choroidal stratification, values within the normal range of CCT showed the greatest reductions, indicating that these values may be more responsive to treatment. Notably, this is the first study to analyze biomarkers provided by SS OCT and OCTA, stratify the choroid, and perform a dichotomous analysis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40942-025-00672-7","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T12:42:48Z","timestamp":1745325768000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Prospective and dichotomous study of biomarkers with swept-source OCT and OCT-angiography in naive patients with diabetic macular edema"],"prefix":"10.1186","volume":"11","author":[{"given":"Marcussi Palata","family":"Rezende","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda Atoui","family":"Faria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Prado","family":"Beraldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Polido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Rubens","family":"Belfort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago","family":"Cabral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,22]]},"reference":[{"issue":"9","key":"672_CR1","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.ophtha.2020.03.021","volume":"127","author":"AR Glassman","year":"2020","unstructured":"Glassman AR, Wells JA 3rd, Josic K, Maguire MG, Antoszyk AN, Baker C, Beaulieu WT, Elman MJ, Jampol LM, Sun JK. Five-year outcomes after initial aflibercept, bevacizumab, or ranibizumab treatment for diabetic macular edema (protocol T extension study). Ophthalmology. 2020;127(9):1201\u201310. https:\/\/doi.org\/10.1016\/j.ophtha.2020.03.021.","journal-title":"Ophthalmology"},{"key":"672_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2021.100951","volume":"84","author":"I La\u00edns","year":"2021","unstructured":"La\u00edns I, Wang JC, Cui Y, Katz R, Vingopoulos F, Staurenghi G, Vavvas DG, Miller JW, Miller JB. Retinal applications of swept source optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA). Prog Retin Eye Res. 2021;84: 100951. https:\/\/doi.org\/10.1016\/j.preteyeres.2021.100951.","journal-title":"Prog Retin Eye Res"},{"issue":"4","key":"672_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1167\/iovs.61.4.29","volume":"61","author":"W Wang","year":"2020","unstructured":"Wang W, Liu S, Qiu Z, He M, Wang L, Li Y, Huang W. Choroidal thickness in diabetes and diabetic retinopathy: a swept source OCT study. Invest Ophthalmol Vis Sci. 2020;61(4):29. https:\/\/doi.org\/10.1167\/iovs.61.4.29.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"672_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0249918","volume":"16","author":"D Podkowinski","year":"2021","unstructured":"Podkowinski D, Beka S, Mursch-Edlmayr AS, Strauss RW, Fischer L, Bolz M. A Swept source optical coherence tomography angiography study: imaging artifacts and comparison of non-perfusion areas with fluorescein angiography in diabetic macular edema. PLoS ONE. 2021;16(4): e0249918. https:\/\/doi.org\/10.1371\/journal.pone.0249918.","journal-title":"PLoS ONE"},{"key":"672_CR5","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/978-1-0716-1138-8_15","volume":"2249","author":"C Rigatto","year":"2021","unstructured":"Rigatto C, Barrett BJ. Randomized controlled trials 5: biomarkers and surrogates\/outcomes. Methods Mol Biol. 2021;2249:261\u201380. https:\/\/doi.org\/10.1007\/978-1-0716-1138-8_15.","journal-title":"Methods Mol Biol"},{"issue":"21","key":"672_CR6","doi-asserted-by":"publisher","first-page":"8077","DOI":"10.3390\/ijms21218077","volume":"21","author":"J Garc\u00eda","year":"2020","unstructured":"Garc\u00eda J, Vargas F. Editorial for special issue- biomarkers of renal disease. Int J Mol Sci. 2020;21(21):8077. https:\/\/doi.org\/10.3390\/ijms21218077.","journal-title":"Int J Mol Sci"},{"issue":"2020","key":"672_CR7","doi-asserted-by":"publisher","first-page":"6655021","DOI":"10.1155\/2020\/6655021","volume":"31","author":"CI Suciu","year":"2020","unstructured":"Suciu CI, Suciu VI, Nicoara SD. Optical coherence tomography (angiography) biomarkers in the assessment and monitoring of diabetic macular edema. J Diabetes Res. 2020;31(2020):6655021. https:\/\/doi.org\/10.1155\/2020\/6655021.","journal-title":"J Diabetes Res"},{"issue":"1","key":"672_CR8","doi-asserted-by":"publisher","first-page":"20544","DOI":"10.1038\/s41598-024-71286-6","volume":"14","author":"Q Gu","year":"2024","unstructured":"Gu Q, Pan T, Cheng R, Huang J, Zhang K, Zhang J, Yang Y, Cheng P, Liu Q, Shen H. Macular vascular and photoreceptor changes for diabetic macular edema at early stage. Sci Rep. 2024;14(1):20544. https:\/\/doi.org\/10.1038\/s41598-024-71286-6.","journal-title":"Sci Rep"},{"issue":"10","key":"672_CR9","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1016\/j.ophtha.2015.06.017","volume":"122","author":"DM Brown","year":"2015","unstructured":"Brown DM, Schmidt-Erfurth U, Do DV, Holz FG, Boyer DS, Midena E, Heier JS, Terasaki H, Kaiser PK, Marcus DM, Nguyen QD, Jaffe GJ, Slakter JS, Simader C, Soo Y, Schmelter T, Yancopoulos GD, Stahl N, Vitti R, Berliner AJ, Zeitz O, Metzig C, Korobelnik JF. Intravitreal aflibercept for diabetic macular edema: 100-week results from the VISTA and VIVID studies. Ophthalmology. 2015;122(10):2044\u201352. https:\/\/doi.org\/10.1016\/j.ophtha.2015.06.017.","journal-title":"Ophthalmology"},{"issue":"3","key":"672_CR10","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1177\/1120672119833270","volume":"30","author":"M Lukic","year":"2020","unstructured":"Lukic M, Williams G, Shalchi Z, Sim D, Patel PJ, Keane PA, Hykin PG, Sivaprasad S, Menon D, Bruynseels A, Hamilton RD, Rajendram R. Intravitreal aflibercept for diabetic macular oedema: moorfields\u2019 real-world 12-month visual acuity and anatomical outcomes. Eur J Ophthalmol. 2020;30(3):557\u201362. https:\/\/doi.org\/10.1177\/1120672119833270.","journal-title":"Eur J Ophthalmol"},{"issue":"45","key":"672_CR11","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000008379","volume":"96","author":"K Michalska-Ma\u0142ecka","year":"2017","unstructured":"Michalska-Ma\u0142ecka K, Heinke KA. Optical coherence tomography angiography in patients with diabetic retinopathy treated with anti-VEGF intravitreal injections: case report. Medicine (Baltimore). 2017;96(45): e8379. https:\/\/doi.org\/10.1097\/MD.0000000000008379.","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"672_CR12","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1007\/s10792-019-01076-x","volume":"39","author":"OA Sorour","year":"2019","unstructured":"Sorour OA, Sabrosa AS, Yasin Alibhai A, Arya M, Ishibazawa A, Witkin AJ, Baumal CR, Duker JS, Waheed NK. Optical coherence tomography angiography analysis of macular vessel density before and after anti-VEGF therapy in eyes with diabetic retinopathy. Int Ophthalmol. 2019;39(10):2361\u201371. https:\/\/doi.org\/10.1007\/s10792-019-01076-x.","journal-title":"Int Ophthalmol"},{"issue":"4","key":"672_CR13","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1001\/jamaophthalmol.2015.565815","volume":"134","author":"TS Hwang","year":"2016","unstructured":"Hwang TS, Gao SS, Liu L, Lauer AK, Bailey ST, Flaxel CJ, Wilson DJ, Huang D, Jia Y. Automated quantification of capillary nonperfusion using optical coherence tomography angiography in diabetic retinopathy. JAMA Ophthalmol. 2016;134(4):367\u201373. https:\/\/doi.org\/10.1001\/jamaophthalmol.2015.565815.","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"672_CR14","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s40942-019-0192-9","volume":"10","author":"FF Conti","year":"2019","unstructured":"Conti FF, Song W, Rodrigues EB, Singh RP. Changes in retinal and choriocapillaris density in diabetic patients receiving anti-vascular endothelial growth factor treatment using optical coherence tomography angiography. Int J Retina Vitreous. 2019;10(5):41. https:\/\/doi.org\/10.1186\/s40942-019-0192-9.","journal-title":"Int J Retina Vitreous"},{"key":"672_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-024-02290-5","author":"J Santamar\u00eda","year":"2024","unstructured":"Santamar\u00eda J, Cobos E, Biarnes M, Caminal JM, Rodriguez-Leor R, Morwani R, Garc\u00eda-Mendieta M, Lorenzo D, Garc\u00eda-Bru P, Arias L. Changes in vessel density patterns assessed with OCTA in patients with diabetic macular edema treated with anti-VEGF therapy. Acta Diabetol. 2024. https:\/\/doi.org\/10.1007\/s00592-024-02290-5.","journal-title":"Acta Diabetol"},{"issue":"5","key":"672_CR16","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.jcjo.2022.04.005","volume":"58","author":"V Kansal","year":"2023","unstructured":"Kansal V, Colleaux K, Rawlings N. OCTA changes following loading phase with intravitreal aflibercept for DME. Can J Ophthalmol. 2023;58(5):480\u201390. https:\/\/doi.org\/10.1016\/j.jcjo.2022.04.005.","journal-title":"Can J Ophthalmol"},{"issue":"8","key":"672_CR17","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1001\/jamaophthalmol.2020.2130","volume":"138","author":"AR Alagorie","year":"2020","unstructured":"Alagorie AR, Nittala MG, Velaga S, Zhou B, Rusakevich AM, Wykoff CC, Sadda SR. Association of intravitreal aflibercept with optical coherence tomography angiography vessel density in patients with proliferative diabetic retinopathy: a secondary analysis of a randomized clinical trial. JAMA Ophthalmol. 2020;138(8):851\u20137. https:\/\/doi.org\/10.1001\/jamaophthalmol.2020.2130.","journal-title":"JAMA Ophthalmol"},{"key":"672_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-015-3143-7","author":"G Di","year":"2015","unstructured":"Di G, Weihong Y, Xiao Z, Zhikun Y, Xuan Z, Yi Q, et al. A morphological study of the foveal avascular zone in patients with diabetes mellitus using optical coherence tomography angiography. Graefe\u2019s Arch Clin Exp Ophthalmol. 2015. https:\/\/doi.org\/10.1007\/s00417-015-3143-7.","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol."},{"key":"672_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-015-3148-2","author":"FJ Freiberg","year":"2015","unstructured":"Freiberg FJ, Pfau M, Wons J, Wirth MA, Becker MD, Michels S. Optical coherence tomography angiography of the foveal avascular zone in diabetic retinopathy. Graefe\u2019s Arch Clin Exp Ophthalmol. 2015. https:\/\/doi.org\/10.1007\/s00417-015-3148-2.","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol."},{"issue":"11","key":"672_CR20","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1097\/IAE.0000000000000849","volume":"35","author":"N Takase","year":"2015","unstructured":"Takase N, Nozaki M, Kato A, Ozeki H, Yoshida M, Ogura Y. Enlargement of foveal avascular zone in diabetic eyes evaluated by en face optical coherence tomography angiography. Retina. 2015;35(11):2377\u201383. https:\/\/doi.org\/10.1097\/IAE.0000000000000849.","journal-title":"Retina"},{"issue":"3","key":"672_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40942-017-0074-y","volume":"19","author":"A Gill","year":"2017","unstructured":"Gill A, Cole ED, Novais EA, Louzada RN, de Carlo T, Duker JS, Waheed NK, Baumal CR, Witkin AJ. Visualization of changes in the foveal avascular zone in both observed and treated diabetic macular edema using optical coherence tomography angiography. Int J Retina Vitreous. 2017;19(3):19. https:\/\/doi.org\/10.1186\/s40942-017-0074-y.","journal-title":"Int J Retina Vitreous"},{"issue":"5","key":"672_CR22","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1080\/09273948.2019.1704028","volume":"29","author":"A Dastiridou","year":"2021","unstructured":"Dastiridou A, Karathanou K, Riga P, Anagnostopoulou S, Balasubramanian S, Mataftsi A, Brazitikos P, Ziakas N, Androudi S. OCT angiography study of the macula in patients with diabetic macular edema treated with intravitreal aflibercept. Ocul Immunol Inflamm. 2021;29(5):926\u201331. https:\/\/doi.org\/10.1080\/09273948.2019.1704028.","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"672_CR23","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1038\/s41598-018-38248-1","volume":"9","author":"C Busch","year":"2019","unstructured":"Busch C, Wakabayashi T, Sato T, Fukushima Y, Hara C, Shiraki N, Winegarner A, Nishida K, Sakaguchi H, Nishida K. Retinal microvasculature and visual acuity after intravitreal aflibercept in diabetic macular edema: an optical coherence tomography angiography study. Sci Rep. 2019;9(1):1561. https:\/\/doi.org\/10.1038\/s41598-018-38248-1.","journal-title":"Sci Rep"},{"issue":"1","key":"672_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0053660","volume":"8","author":"NK Wang","year":"2013","unstructured":"Wang NK, Lai CC, Chou CL, Chen YP, Chuang LH, Chao AN, Tseng HJ, Chang CJ, Wu WC, Chen KJ, Tsang SH. Choroidal thickness and biometric markers for the screening of lacquer cracks in patients with high myopia. PLoS ONE. 2013;8(1): e53660. https:\/\/doi.org\/10.1371\/journal.pone.0053660.","journal-title":"PLoS ONE"},{"issue":"3","key":"672_CR25","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.ajo.2010.04.018","volume":"150","author":"V Manjunath","year":"2010","unstructured":"Manjunath V, Taha M, Fujimoto JG, Duker JS. Choroidal thickness in normal eyes measured using cirrus HD optical coherence tomography. Am J Ophthalmol. 2010;150(3):325-329.e1. https:\/\/doi.org\/10.1016\/j.ajo.2010.04.018.","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"672_CR26","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1007\/s00417-018-4072-z","volume":"256","author":"A Campos","year":"2018","unstructured":"Campos A, Campos EJ, do Carmo A, Patr\u00edcio M, Castro de Sousa JP, Ambr\u00f3sio AF, Silva R. Choroidal thickness changes stratified by outcome in real-world treatment of diabetic macular edema. Graefes Arch Clin Exp Ophthalmol. 2018;256(10):1857\u201365. https:\/\/doi.org\/10.1007\/s00417-018-4072-z.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2020","key":"672_CR27","doi-asserted-by":"publisher","first-page":"5708354","DOI":"10.1155\/2020\/5708354","volume":"11","author":"V Sarda","year":"2020","unstructured":"Sarda V, Eymard P, Hrarat L, Fajnkuchen F, Giocanti-Aur\u00e9gan A. Comparison of the effect of ranibizumab and aflibercept on changes in macular choroidal thickness in patients treated for diabetic macular edema. J Ophthalmol. 2020;11(2020):5708354. https:\/\/doi.org\/10.1155\/2020\/5708354.","journal-title":"J Ophthalmol"},{"key":"672_CR28","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/3033219","author":"N Dou","year":"2021","unstructured":"Dou N, Yu S, Tsui CK, Yang B, Lin J, Lu X, Xu Y, Wu B, Zhao J, Liang X. Choroidal vascularity index as a biomarker for visual response to antivascular endothelial growth factor treatment in diabetic macular edema. J Diabetes Res. 2021. https:\/\/doi.org\/10.1155\/2021\/3033219.","journal-title":"J Diabetes Res"}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-025-00672-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40942-025-00672-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-025-00672-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T12:42:49Z","timestamp":1745325769000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalretinavitreous.biomedcentral.com\/articles\/10.1186\/s40942-025-00672-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,22]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["672"],"URL":"https:\/\/doi.org\/10.1186\/s40942-025-00672-7","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,22]]},"assertion":[{"value":"12 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study adhered to the guidelines set forth in Resolution 196\/96 by the National Health Council of the Ministry of Health. The research protocol was submitted for evaluation and received formal approval from the Ethics Committee of the Hospital Regional do C\u00e2ncer da Santa Casa de Miseric\u00f3rdia de Presidente Prudente \u2013 SP (CAAE\u201419386619.1.0000.8247).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}